Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
July 25 2024 - 7:00AM
Business Wire
Company to Host Conference Call to Discuss
Results at 8:00 a.m. Eastern Time on August 8, 2024
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical
company, today announced that it will report its financial results
for the second quarter ended June 30, 2024, on Wednesday, August 7,
2024, after the market close. The Company will also post its second
quarter Letter to Stockholders to the “Investors” section of its
website, harrow.com. Harrow will host a conference call and live
webcast at 8:00 a.m. Eastern Time on Thursday, August 8, 2024, to
discuss the results and provide a business update.
Conference Call Information
Participants can access the live conference call via webcast on
the “Investors” page of Harrow’s website. To participate via
telephone, please register in advance using this link. Upon
registration, all telephone participants will receive a
confirmation email with detailed instructions, including a unique
dial-in number and PIN, for accessing the call. A replay of the
conference call and webcast will be archived on the Company’s
website for one year.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical
company engaged in the discovery, development, and
commercialization of innovative ophthalmic pharmaceutical products
for the North American market. Harrow helps eyecare professionals
preserve the gift of sight by making its comprehensive portfolio of
prescription and non-prescription pharmaceutical products
accessible and affordable to millions of patients each year. For
more information about Harrow, please visit harrow.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725144463/en/
Jamie Webb Director of Communications and Investor Relations
jwebb@harrowinc.com 615-733-4737
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Sep 2024 to Oct 2024
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Oct 2023 to Oct 2024